◆ Mixed
Natco Pharma hikes investment in US-based eGenesis to $16.7 million
29 Sept 2026 · BS Companies
Natco Pharma Ltd on Monday said it has decided to increase its proposed investment in US-based biotechnology firm eGenesis Inc to USD 16.70 million (around Rs 139 crore) from the previously disclosed amount of USD 14 million.
Key facts
- Dates in focus
- October 31
Market context
- Sector exposure: Pharma & Healthcare.
In this story
Pharma & Healthcare
Related coverage
Market wrap: ITC, BSE, HCL Tech, Asian Paints top gainers and losers on Nifty and Sensex on Monday
Stock Market Today LIVE: Sensex Rises 500 Points, Nifty 50 Holds 22,700; India VIX Leaps 7%; Trent Rallies 12%
Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath
Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in Nifty 2027 index review
Buy, Sell Or Hold: HDFC Bank, Sun Pharma, Rallis India, Trent | Ask Profit